 Connection
Mary Bessesen to Anti-Bacterial Agents
This is a "connection" page, showing publications Mary Bessesen has written about Anti-Bacterial Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.295 |
|
|
|
-
Fugit RV, McCoury JB, Bessesen MT. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program. Am J Health Syst Pharm. 2023 05 24; 80(Suppl 2):S49-S54.
Score: 0.117
-
Bessesen MT, Doros G, Henrie AM, Harrington KM, Hermos JA, Bonomo RA, Ferguson RE, Huang GD, Brown ST. A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID). BMC Infect Dis. 2020 Jan 08; 20(1):23.
Score: 0.093
-
Koeppe J, Belknap R, Bessesen M. Mycobacterium avium complex peritonitis in the setting of cirrhosis: case report and review of the literature. Scand J Infect Dis. 2004; 36(8):615-7.
Score: 0.031
-
Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis. 2013 Nov; 57(9):1256-65.
Score: 0.030
-
Hojat LS, Bessesen MT, Huang M, Reid M, Knepper BC, Miller MA, Shihadeh KC, Fugit RV, Jenkins TC. Effectiveness of Shorter Versus Longer Durations of Therapy for Common Inpatient Infections Associated With Bacteremia: A Multicenter, Propensity-Weighted Cohort Study. Clin Infect Dis. 2020 12 15; 71(12):3071-3078.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|